News
Report: UKEGS 2024
It was an incredible experience heading down to UKEGS 2024 earlier this month in Southampton. The entire Glaucoma UK team, along with the UKEGS overseeing panel Nishani Amerasinghe, Andrew Tatham, Professir Anthony King and Professor Gus Gazzard, took great care...
Preview: UKEGS 2024
Pretty soon it’s going to be the 9th of October, and a quick Wikipedia search will tell you of how this day in history has seen the founding of the Kingdom of Valencia, the initial whispers of the Prague Astronomical...
Ophthalmic surgeon returns to London Marathon after 31 years for Glaucoma UK
Michael Miller, in commemoration of Glaucoma UK's 50th anniversary, has achieved a remarkable feat by completing this year's London Marathon, three decades after he last completed the challenge in 1993, which he also ran in support of the charity.
Glaucoma UK and The Royal College of Ophthalmologists announce research award 2024
Glaucoma UK and The Royal College of Ophthalmologists are collaborating to run this prestigious award which has previously funded a range of research topics from prospective stem cell treatments to the use of big data in patient risk stratification.
Introducing: iGLEAMS-3
30 September (Colchester FirstSite) – 1 October (Colchester ICENI Centre)
BELKIN Vision is pleased to announce FDA clearance for its glaucoma laser, the Eagle device
BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.
Glaucoma UK’s Road Safety Week campaign encourages people to keep their vision road-ready
Road Safety Week will run from 19-25 November 2023 and Glaucoma UK, a registered charity that provides support for everyone living with glaucoma is encouraging people to keep their vision road-ready.
Midland Eye performs its first Presserflo Microshunt to treat Glaucoma
Eye clinic, Midland Eye, announces the success of its first sight-saving Preserflo Microshunt glaucoma procedure.
Ciliatech presents preliminary results on treating glaucoma with CID at Ophthalmology Futures Symposium
Ciliatech presents preliminary one-year study results on treating open- and narrow-angle glaucoma with CID at Ophthalmology Futures Symposium.
Glaucoma UK’s National Eye Health Week campaign highlights the significance of timely information in safeguarding eyesight
Glaucoma UK’s campaign for National Eye Health Week 2023, which will run from 18-24 September, focuses on delivering essential bitesize information about glaucoma that can be read or viewed in under one minute.